IDiyas

For the Inventor, By the Inventor

Skokie, IL, United States of America

Donald W Hansen, Jr

USPTO Granted Patents = 73

Average Co-Inventor Count = 5.0

ph-index = 13

Forward Citations = 617(Granted Patents)


Inventors with similar research interests:


Location History:

  • Chicago, IL (US) (1985 - 1994)
  • St. Louis, MO (US) (2002 - 2003)
  • Skokie, IL (US) (1990 - 2007)

Company Filing History:

goldMedal56 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal14 out of 200 
 
Pharmacia Corporation
 patents
bronzeMedal1 out of 33 
 
G.d. Searle LLC
 patents
4. 1 out of 1 
 
Monsanto/g.d. Searle
 patent
5. 1 out of 832,680 
Other
 patents

Years Active: 1985-2007

Loading Chart...
73 patents (USPTO):Explore Patents
1. 7196118 - Amidino compounds useful as nitric oxide synthase inhibitors (2007-03-27),
2. 7102013 - Methods of making amidino compounds useful as nitric oxide synthase inhibitors (2006-09-05),
3. 7005450 - 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors (2006-02-28),
4. 6951889 - 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors (2005-10-04),
5. 6914158 - Amidino compounds useful as nitric oxide synthase inhibitors (2005-07-05),
6. 6828456 - 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors (2004-12-07),
7. 6774126 - Pyrrolo[1,2-b][1,2,4]oxadiazine diones useful as nitric oxide synthase inhibitors (2004-08-10),
8. 6756406 - 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors (2004-06-29),
9. 6638758 - Process for the enzymatic resolution of lactams (2003-10-28),
10. 6586474 - Amidino compounds useful as nitric oxide synthase inhibitors (2003-07-01),
11. 6586471 - Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors (2003-07-01),
12. 6576780 - Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors (2003-06-10),
13. 6552052 - Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors (2003-04-22),
14. 6545170 - 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors (2003-04-08),
15. 6495544 - Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase (2002-12-17),

Title: Donald W Hansen, Jr: Innovator Extraordinaire

Introduction:

Throughout his illustrious career, Donald W Hansen, Jr has consistently demonstrated his commitment to excellence and innovation. Hailing from Skokie, IL (US), Hansen has made remarkable contributions to various industries through his groundbreaking inventions. With an impressive portfolio of patents and a reputation for pushing the boundaries of technology, Hansen's work has earned him numerous accolades and cemented his status as a trailblazer in his field.

Latest Patents:

Among Hansen's recent patents, his work on amidino compounds stands out for its potential impact on therapy. The patented compounds and their derivatives have shown promise as nitric oxide synthase inhibitors, opening up new avenues for treating various medical conditions. These compounds, when utilized, have the potential to revolutionize therapies by targeting specific pathways in the human body.

Career Highlights:

Over the course of his career, Hansen has amassed an impressive number of patents, with a total tally of 73 to his name. This demonstrates his relentless pursuit of innovation and his ability to consistently deliver groundbreaking solutions. Hansen's contributions have not only improved existing technologies but have also left an indelible mark on a multitude of industries.

Collaborations:

Donald W Hansen, Jr's innovative prowess and dedication to his craft have led him to collaborate with prominent organizations during his career. These collaborations have further enhanced his ability to advance cutting-edge technologies. Notably, he has worked with renowned companies such as G.D. Searle & Company and Pharmacia Corporation, both of which are recognized leaders in their respective fields.

Furthermore, Hansen has had the privilege of collaborating with esteemed colleagues, including Barnett S Pitzele and E Ann Hallinan. This collaborative spirit has fostered an environment conducive to groundbreaking research, ultimately resulting in transformative inventions.

Conclusion:

Donald W Hansen, Jr has established himself as a visionary innovator with a remarkable track record. Through his numerous patents and groundbreaking inventions, he has left an indelible mark on various industries. Hansen's commitment to excellence and his relentless pursuit of innovation continue to inspire and drive advancements in technology and therapy.

As a leading figure in his field, Hansen's work not only improves existing technologies but also opens up new possibilities for the future. By leveraging his expertise, he propels industries forward and plays a crucial role in shaping the future of innovation.

For more information about Donald W Hansen, Jr and his remarkable career, visit our website idiyas.com.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…